risperidone has been researched along with Adult Refsum Disease in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Excerpt | Relevance | Reference |
---|---|---|
"Infantile Refsum disease (IRD) appears with varying degrees of impaired vision, hearing loss, developmental delays, and neuromotor deficiencies." | 1.31 | Infantile refsum disease in four Amish sibs. ( Bader, PI; Cangany, N; Dougherty, S; Jackson, CE; Raymond, G, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bader, PI | 1 |
Dougherty, S | 1 |
Cangany, N | 1 |
Raymond, G | 1 |
Jackson, CE | 1 |
1 other study available for risperidone and Adult Refsum Disease
Article | Year |
---|---|
Infantile refsum disease in four Amish sibs.
Topics: Adolescent; Antidepressive Agents; Child; Consanguinity; Female; Fluoxetine; Humans; Lorazepam; Male | 2000 |